A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer

Gynecologic Oncology

Volumn 127, Issue 2, 2012, Pages 420-425

  Fauci, Janelle M ^a   Straughn Jr , J Michael ^a   Ferrone, Soldano ^b   Buchsbaum, Donald J ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c The University of Alabama at Birmingham   (United States)

Author keywords

B7 H3; B7 H4; Ovarian cancer

Indexed keywords

B7 ANTIGEN; B7 H3 PROTEIN; CA 125 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; JANUS KINASE 2; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; PROTEIN MCL 1; SMALL INTERFERING RNA; STAT3 PROTEIN; SURVIVIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; V SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1;

ANTIGEN EXPRESSION; APOPTOSIS; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CELL MIGRATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; ENZYME INACTIVATION; HELPER CELL; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; KIDNEY CANCER; METASTASIS; NONHUMAN; OVARY CANCER; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER; T LYMPHOCYTE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT;

B7 ANTIGENS; FEMALE; HUMANS; OVARIAN NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; V-SET DOMAIN-CONTAINING T-CELL ACTIVATION INHIBITOR 1;

EID: 84867404126     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.08.017     Document Type: Review

References (47)

1. A.K. Abbas The control of T cell activation vs. tolerance Autoimmun Rev 2 3 May 2003 115 118
2. J.A. Berzofsky, and M. Terabe NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis J Immunol 180 6 Mar 15 2008 3627 3635
3. +CD25-T lymphocytes J Immunol 181 2 Jul 15 2008 1025 1033
4. W.H. Fridman, J. Galon, F. Pages, E. Tartour, C. Sautes-Fridman, and G. Kroemer Prognostic and predictive impact of intra- and peritumoral immune infiltrates Cancer Res. 71 17 Sep 2011 5601 5605
5. A. Facciabene, X. Peng, I.S. Hagemann, K. Balint, A. Barchetti, and L.P. Wang Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells Nature 475 7355 Jul 14 2011 226 230
6. S.J. Antonia, M. Extermann, and R.A. Flavell Immunologic nonresponsiveness to tumors Crit Rev Oncog 9 1 1998 35 41
7. C. He, H. Qiao, H. Jiang, and X. Sun The inhibitory role of B7-H4 in antitumor immunity: association with cancer progression and survival Clin Dev Immunol 2011 2011 [695834] [Electronic publication 2011 Oct 13]
8. F.H. Igney, and P.H. Krammer Immune escape of tumors: apoptosis resistance and tumor counterattack J Leukoc Biol 71 6 Jun 2002 907 920
9. M. Collins, V. Ling, and B.M. Carreno The B7 family of immune-regulatory ligands Genome Biol 6 6 2005 223
10. B. Seliger, F.M. Marincola, S. Ferrone, and H. Abken The complex role of B7 molecules in tumor immunology Trends Mol Med 14 12 Dec 2008 550 559
11. M. Hashiguchi, H. Kobori, P. Ritprajak, Y. Kamimura, H. Kozono, and M. Azuma Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses Proc Natl Acad Sci U S A 105 30 Jul 29 2008 10495 10500
12. J. Leitner, C. Klauser, W.F. Pickl, J. Stockl, O. Majdic, and A.F. Bardet B7-H3 is a potent inhibitor of human T-cell activation: no evidence for B7-H3 and TREML2 interaction Eur J Immunol 39 7 Jul 2009 1754 1764
13. A. Fukushima, T. Sumi, K. Fukuda, N. Kumagai, T. Nishida, and T. Yamazaki B7-H3 regulates the development of experimental allergic conjunctivitis in mice Immunol Lett 113 1 Oct 31 2007 52 57
14. + cytolytic T cells J Immunol 173 9 Nov 1 2004 5445 5450
15. O. Nagashima, N. Harada, Y. Usui, T. Yamazaki, H. Yagita, and K. Okumura B7-H3 contributes to the development of pathogenic Th2 cells in a murine model of asthma J Immunol 181 6 Sep 15 2008 4062 4071
16. W.K. Suh, B.U. Gajewska, H. Okada, M.A. Gronski, E.M. Bertram, and W. Dawicki The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses Nat Immunol 4 9 Sep 2003 899 906
17. X. Zang, P.S. Sullivan, R.A. Soslow, R. Waitz, V.E. Reuter, and A. Wilton Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas Mod Pathol. 23 8 Aug 2010 1104 1112
18. S.A. Boorjian, Y. Sheinin, P.L. Crispen, S.A. Farmer, C.M. Lohse, and S.M. Kuntz T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival Clin Cancer Res 14 15 Aug 1 2008 4800 4808
19. P.L. Crispen, Y. Sheinin, T.J. Roth, C.M. Lohse, S.M. Kuntz, and X. Frigola Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma Clin Cancer Res 14 16 Aug 15 2008 5150 5157
20. J. Jiang, Y. Zhu, C. Wu, Y. Shen, W. Wei, and L. Chen Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer Cancer Immunol Immunother. 59 11 Nov 2010 1707 1714
21. M. Loos, D.M. Hedderich, M. Ottenhausen, N.A. Giese, M. Laschinger, and I. Esposito Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer BMC Cancer 9 2009 463
22. J. Sun, L.J. Chen, G.B. Zhang, J.T. Jiang, M. Zhu, and Y. Tan Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma Cancer Immunol Immunother. 59 8 Aug 2010 1163 1171
23. C.P. Wu, J.T. Jiang, M. Tan, Y.B. Zhu, M. Ji, and K.F. Xu Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis World J Gastroenterol 12 3 Jan 21 2006 457 459
24. X. Zang, R.H. Thompson, H.A. Al-Ahmadie, A.M. Serio, V.E. Reuter, and J.A. Eastham B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome Proc Natl Acad Sci U S A 104 49 Dec 4 2007 19458 19463
25. A. Gregorio, M.V. Corrias, R. Castriconi, A. Dondero, M. Mosconi, and C. Gambini Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule Histopathology 53 1 Jul 2008 73 80
26. T.J. Roth, Y. Sheinin, C.M. Lohse, S.M. Kuntz, X. Frigola, and B.A. Inman B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy Cancer Res 67 16 Aug 15 2007 7893 7900
27. I. Yamato, M. Sho, T. Nomi, T. Akahori, K. Shimada, and K. Hotta Clinical importance of B7-H3 expression in human pancreatic cancer Br J Cancer 101 10 Nov 17 2009 1709 1716
28. H. Xu, I.Y. Cheung, H.F. Guo, and N.K. Cheung MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors Cancer Res 69 15 Aug 1 2009 6275 6281
29. Y.W. Chen, C. Tekle, and O. Fodstad The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion Curr Cancer Drug Targets 8 5 Aug 2008 404 413
30. Liu H, Tekle C, Chen YW, Kristian A, Zhao Y, Zhou M, et al. B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation. Mol Cancer Ther. Jun;10(6):960-71.
31. G.L. Sica, I.H. Choi, G. Zhu, K. Tamada, S.D. Wang, and H. Tamura B7-H4, a molecule of the B7 family, negatively regulates T cell immunity Immunity 18 6 Jun 2003 849 861
32. X. Zang, P. Loke, J. Kim, K. Murphy, R. Waitz, and J.P. Allison B7x: a widely expressed B7 family member that inhibits T cell activation Proc Natl Acad Sci U S A 100 18 Sep 2 2003 10388 10392
33. B.M. Carreno, and M. Collins BTLA: a new inhibitory receptor with a B7-like ligand Trends Immunol 24 10 Oct 2003 524 527
34. D.V. Prasad, S. Richards, X.M. Mai, and C. Dong B7S1, a novel B7 family member that negatively regulates T cell activation Immunity 18 6 Jun 2003 863 873
35. I.H. Choi, G. Zhu, G.L. Sica, S.E. Strome, J.C. Cheville, and J.S. Lau Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family J Immunol 171 9 Nov 1 2003 4650 4654
36. S. Salceda, T. Tang, M. Kmet, A. Munteanu, M. Ghosh, and R. Macina The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation Exp Cell Res 306 1 May 15 2005 128 141
37. A.E. Krambeck, R.H. Thompson, H. Dong, C.M. Lohse, E.S. Park, and S.M. Kuntz B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival Proc Natl Acad Sci U S A 103 27 Jul 5 2006 10391 10396
38. B. Tringler, S. Zhuo, G. Pilkington, K.C. Torkko, M. Singh, and M.S. Lucia B7-h4 is highly expressed in ductal and lobular breast cancer Clin Cancer Res 11 5 Mar 1 2005 1842 1848
39. L. Cheng, J. Jiang, R. Gao, S. Wei, F. Nan, and S. Li B7-H4 expression promotes tumorigenesis in ovarian cancer Int J Gynecol Cancer 19 9 Dec 2009 1481 1486
40. B. Tringler, W. Liu, L. Corral, K.C. Torkko, T. Enomoto, and S. Davidson B7-H4 overexpression in ovarian tumors Gynecol Oncol 100 1 Jan 2006 44 52
41. I. Simon, S. Zhuo, L. Corral, E.P. Diamandis, M.J. Sarno, and R.L. Wolfert B7-H4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer Cancer Res 66 3 Feb 1 2006 1570 1575
42. I. Simon, D. Katsaros, I. Rigault de la Longrais, M. Massobrio, A. Scorilas, and N.W. Kim B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression Gynecol Oncol 106 2 Aug 2007 334 341
43. I. Kryczek, S. Wei, G. Zhu, L. Myers, P. Mottram, and P. Cheng Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma Cancer Res 67 18 Sep 15 2007 8900 8905
44. I. Kryczek, L. Zou, P. Rodriguez, G. Zhu, S. Wei, and P. Mottram B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma J Exp Med 203 4 Apr 17 2006 871 881
45. Y. Zheng, D. Katsaros, S.J. Shan, I.R. de la Longrais, M. Porpiglia, and A. Scorilas A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy Clin Cancer Res 13 23 Dec 1 2007 6984 6992
46. I. Simon, Y. Liu, K.L. Krall, N. Urban, R.L. Wolfert, and N.W. Kim Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer Gynecol Oncol 106 1 Jul 2007 112 118
47. K. Oikonomopoulou, L. Li, Y. Zheng, I. Simon, R.L. Wolfert, and D. Valik Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel Br J Cancer 99 7 Oct 7 2008 1103 1113